Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Liver Cirrhosis

  Free Subscription


3 BMC Gastroenterol
3 Clin Res Hepatol Gastroenterol
1 Dig Dis
2 Digestion
2 Gastroenterology
1 Gut
4 Hepatology
1 J Gastroenterol
1 J Gastroenterol Hepatol
3 J Hepatol
1 Lancet
2 PLoS One
4 Transplant Proc
1 Z Gastroenterol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    BMC Gastroenterol

  1. HAYASHI T, Takatori H, Horii R, Nio K, et al
    Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
    BMC Gastroenterol. 2019;19:217.
    PubMed     Text format     Abstract available

  2. PARK HJ, Park JY, Jung SM, Song JJ, et al
    Fibrosis-4 index at diagnosis is associated with all-cause mortality in patients with microscopic polyangiitis and granulomatosis with polyangiitis.
    BMC Gastroenterol. 2019;19:90.
    PubMed     Text format     Abstract available

  3. DESALEGN H, Aberra H, Berhe N, Medhin G, et al
    Predictors of mortality in patients under treatment for chronic hepatitis B in Ethiopia: a prospective cohort study.
    BMC Gastroenterol. 2019;19:74.
    PubMed     Text format     Abstract available

    Clin Res Hepatol Gastroenterol

  4. GUILLAUD O, Dumortier J, Traclet J, Restier L, et al
    Assessment of liver fibrosis by transient elastography (Fibroscan((R))) in patients with A1AT deficiency.
    Clin Res Hepatol Gastroenterol. 2019;43:77-81.
    PubMed     Text format     Abstract available

  5. YU C, Wang L, Xue H, Lin H, et al
    Association of glycated hemoglobin with the risk of advanced fibrosis in non-alcoholic fatty liver disease patients without diabetes.
    Clin Res Hepatol Gastroenterol. 2019;43:58-66.
    PubMed     Text format     Abstract available

  6. CASTRO NARRO GE, Consuelo Sanchez A, Salazar Martinez A, Gamboa Dominguez A, et al
    The silent course of liver steatosis and fibrosis in an adult patient with Cholesteryl Ester Storage Disease.
    Clin Res Hepatol Gastroenterol. 2019;43:e4-e6.
    PubMed     Text format    

    Dig Dis

  7. MANZHALII E, Virchenko O, Falalyeyeva T, Moiseienko V, et al
    Hepatic Encephalopathy Aggravated by Systemic Inflammation.
    Dig Dis. 2019 Jun 6:1-9. doi: 10.1159/000500717.
    PubMed     Text format     Abstract available


  8. BUECHTER M, Thimm J, Baba HA, Bertram S, et al
    Liver Maximum Capacity: A Novel Test to Accurately Diagnose Different Stages of Liver Fibrosis.
    Digestion. 2019;100:45-54.
    PubMed     Text format     Abstract available

  9. ARAI M, Matsumura T, Ohta Y, Kiyono S, et al
    Long-Term Prognosis of Patients with Obscure Gastrointestinal Bleeding: A Retrospective Cohort Study.
    Digestion. 2019;100:37-44.
    PubMed     Text format     Abstract available


  10. FAN W, Liu T, Chen W, Hammad S, et al
    ECM1 Prevents Activation of Transforming Growth Factor beta, Hepatic Stellate Cells, and Fibrogenesis in Mice.
    Gastroenterology. 2019 Jul 27. pii: S0016-5085(19)41133.
    PubMed     Text format     Abstract available

  11. MORAN-SALVADOR E, Garcia-Macia M, Sivaharan A, Sabater L, et al
    Fibrogenic Activity of MECP2 is Regulated by Phosphorylation in Hepatic Stellate Cells.
    Gastroenterology. 2019 Jul 25. pii: S0016-5085(19)41126.
    PubMed     Text format     Abstract available


  12. SINGHI AD, Nikiforova MN, Chennat J, Papachristou GI, et al
    Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures.
    Gut. 2019 Apr 10. pii: gutjnl-2018-317817. doi: 10.1136/gutjnl-2018-317817.
    PubMed     Text format     Abstract available


  13. RAMAMURTHY N, Marchi E, Ansari MA, Pedergnana V, et al
    Impact of IFNL4 genotype on Interferon-stimulated Gene Expression during DAA therapy for Hepatitis C.
    Hepatology. 2018 Mar 13. doi: 10.1002/hep.29877.
    PubMed     Text format     Abstract available

  14. CAUSSY C, Hsu C, Lo MT, Liu A, et al
    Novel link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD.
    Hepatology. 2018 Mar 23. doi: 10.1002/hep.29892.
    PubMed     Text format     Abstract available

  15. YANG NB, Li GX, Chu JG, Wang YJ, et al
    Letter to the Editors: Consider More Factors When Studying Risk of Cirrhosis and Hepatocellular Cancer in NAFLD Patients.
    Hepatology. 2019 Dec 17. doi: 10.1002/hep.31075.
    PubMed     Text format     Abstract available

  16. CHANDRAMOULI S, Lee WM, Lo J, Toomay S, et al
    Prophylactic Transjugular Intrahepatic Portosystemic Shunt Placement for Cirrhosis Management in Pregnancy.
    Hepatology. 2019 Dec 21. doi: 10.1002/hep.31081.
    PubMed     Text format     Abstract available

    J Gastroenterol

  17. SUDA G, Kurosaki M, Itakura J, Izumi N, et al
    Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection.
    J Gastroenterol. 2018 Jul 17. pii: 10.1007/s00535-018-1495.
    PubMed     Text format     Abstract available

    J Gastroenterol Hepatol

  18. ATSUKAWA M, Tsubota A, Takaguchi K, Toyoda H, et al
    Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema.
    J Gastroenterol Hepatol. 2019 Dec 27. doi: 10.1111/jgh.14965.
    PubMed     Text format     Abstract available

    J Hepatol

  19. GARCIA-TSAO G, Bosch J, Kayali Z, Harrison SA, et al
    Randomized Placebo-Controlled Trial of Emricasan in Non-alcoholic Steatohepatitis (NASH) Cirrhosis with Severe Portal Hypertension.
    J Hepatol. 2019 Dec 20. pii: S0168-8278(19)30724.
    PubMed     Text format     Abstract available

  20. RODRIGUES PM, Perugorria MJ, Santos-Laso A, Bujanda L, et al
    Primary biliary cholangitis: a tale of epigenetically-induced secretory failure?
    J Hepatol. 2018 Sep 4. pii: S0168-8278(18)32362.
    PubMed     Text format     Abstract available

  21. CUBERO FJ, Peng J, Liao L, Su H, et al
    Inactivation of Caspase 8 in liver parenchymal cells confers protection against murine obstructive cholestasis.
    J Hepatol. 2018 Aug 22. pii: S0168-8278(18)32297.
    PubMed     Text format     Abstract available


  22. HARRISON SA, Bashir MR, Guy CD, Zhou R, et al
    Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet. 2019 Nov 11. pii: S0140-6736(19)32517.
    PubMed     Text format     Abstract available

    PLoS One

  23. TOLEDANO MB, Mukherjee SK, Howell J, Westaby D, et al
    The emerging burden of liver disease in cystic fibrosis patients: A UK nationwide study.
    PLoS One. 2019;14:e0212779.
    PubMed     Text format     Abstract available

  24. LEE YC, Hu TH, Hung CH, Lu SN, et al
    The change in liver stiffness, controlled attenuation parameter and fibrosis-4 index for chronic hepatitis C patients with direct-acting antivirals.
    PLoS One. 2019;14:e0214323.
    PubMed     Text format     Abstract available

    Transplant Proc

  25. SHIMIZU S, Ohira M, Nakano R, Imaoka Y, et al
    Management of Refractory Ascites for Liver Transplant Candidates: A Novel Cell-free and Concentrated Ascites Reinfusion Therapy.
    Transplant Proc. 2019;51:2740-2744.
    PubMed     Text format     Abstract available

  26. EMEK E, Serin A, Sahin T, Yazici P, et al
    Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center Experience.
    Transplant Proc. 2019 Aug 9. pii: S0041-1345(18)31854.
    PubMed     Text format     Abstract available

  27. BAYRAMOV N, Yilmaz S, Salahova S, Bashkiran A, et al
    Liver Graft and Spleen Elastography After Living Liver Transplantation: Our First Results.
    Transplant Proc. 2019 Aug 9. pii: S0041-1345(18)31689.
    PubMed     Text format     Abstract available

  28. ULKU A, Akcam AT
    Importance of Multislice Computed Tomography in Determining the Severity of Chronic Liver Disease State.
    Transplant Proc. 2019;51:2408-2412.
    PubMed     Text format     Abstract available

    Z Gastroenterol

  29. GUNDLING F, Rathmayer M, Koller L, Wilke M, et al
    [Prognostic significance and economic burden of hepatic encephalopathy in liver cirrhosis in German hospitals based on G-DRG data].
    Z Gastroenterol. 2019 Dec 20. doi: 10.1055/a-1068-3138.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.